Photo from academic.microsoft.com
To use a non‐biased assay for circulating tumour cells (CTCs) in patients with prostate cancer (PCa) in order to identify non‐traditional CTC phenotypes potentially excluded by conventional detection methods that… Click to show full abstract
To use a non‐biased assay for circulating tumour cells (CTCs) in patients with prostate cancer (PCa) in order to identify non‐traditional CTC phenotypes potentially excluded by conventional detection methods that are reliant on antigen‐ and/or size‐based enrichment.
Keywords:
tumour cells;
prostate cancer;
phenotypic diversity;
circulating tumour;
diversity circulating
Journal Title: BJU International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: BJU International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!